Anda Repository Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANDA REPOSITORY, and what generic and branded alternatives to ANDA REPOSITORY drugs are available?
ANDA REPOSITORY has twenty-five approved drugs.
Drugs and US Patents for Anda Repository
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anda Repository | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 214201-001 | Jun 27, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Anda Repository | LORAZEPAM | lorazepam | TABLET;ORAL | 072555-002 | Mar 29, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Anda Repository | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 089359-001 | Jul 25, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Anda Repository | CEFTRIAXONE SODIUM | ceftriaxone sodium | INJECTABLE;INJECTION | 091117-001 | Jan 20, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.